Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
Clinical Colorectal Cancer
Journal
Overview
Identity
Overview
Publication Venue For
Usefulness of Restaging Pelvis Magnetic Resonance Imaging After Neoadjuvant Concurrent Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer
. 19:e281-e287.
2020
The Prevalence of DPYD*9A (c.85T>C) Genotype and the Genotype-Phenotype Correlation in Patients with Gastrointestinal Malignancies Treated With Fluoropyrimidines: Updated Analysis
. 18:e280-e286.
2019
A Randomized, Phase II Trial of Cetuximab With or Without PX-866, an Irreversible Oral Phosphatidylinositol 3-Kinase Inhibitor, in Patients With Metastatic Colorectal Carcinoma
. 15:337-344.e2.
2016
Comparative Survival of Patients with Anal Adenocarcinoma, Squamous Cell Carcinoma of the Anus, and Rectal Adenocarcinoma
. 15:47-53.
2016
SPIRITT: A randomized, multicenter, phase II study of panitumumab with FOLFIRI and bevacizumab with FOLFIRI as second-line treatment in patients with unresectable wild type KRAS metastatic colorectal cancer
. 14:72-80.
2015
Treatment rationale and study design for a randomized, double-blind, placebo-controlled phase II study evaluating onartuzumab (MetMAb) in combination with bevacizumab plus mFOLFOX-6 in patients with previously untreated metastatic colorectal cancer
. 12:218-222.
2013
Identity
International Standard Serial Number (issn)
1533-0028
Electronic International Standard Serial Number (eissn)
1938-0674
